About NXT-Dx
NXT-Dx is a company based in Gentbrugge (Belgium) founded in 2011 by Maarten Braspenning was acquired by Diagenode in August 2018. NXT-Dx operates in a competitive market with competitors including Depixus, Genomics, Seven Bridges Genomics, Hexagon Bio and BC Platforms, among others.
- Headquarter Gentbrugge, Belgium
- Founders Maarten Braspenning
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of NXT-Dx
Investments & Acquisitions by NXT-Dx
Financial Statements - NXT-Dx
Nxt-Dx Comparisons
Competitors of NXT-Dx
NXT-Dx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Depixus, Genomics, Seven Bridges Genomics, Hexagon Bio and BC Platforms, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Single-molecule genetic and epigenetic sequencing solutions are provided.
|
|
| domain | founded_year | HQ Location |
Genomic risk assessment and prevention platform is provided.
|
|
| domain | founded_year | HQ Location |
Cloud-based platform to analyze, store, and act on genomic data.
|
|
| domain | founded_year | HQ Location |
Bioinformatics tools are provided for analyzing microbial genomic sequencing data.
|
|
| domain | founded_year | HQ Location |
Platforms for genomic data analysis and management are provided.
|
|
| domain | founded_year | HQ Location |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
Latest news on Nxt-Dx
Frequently Asked Questions about NXT-Dx
NXT-Dx was founded in 2011.
NXT-Dx is headquartered in Gentbrugge, Belgium. It is registered at Gentbrugge, East Flanders, Belgium.
NXT-Dx was founded in 2011 and is based in Gentbrugge, Belgium. Services in epigenetics are provided to the life science community, including Infinium Methylation EPIC array, MBD-sequencing, MeDIP-seq, Reduced Representation Bisulfite Sequencing, and bisulfite sequencing variants for targeted, genome-wide, or whole-genome analysis. Additional offerings encompass genomics, transcriptomics, metagenomics, and bioinformatics support. Operations focus on advancing epigenetic and related genomic studies.
NXT-Dx's top competitors include Novogene Corporation, Depixus and Ingenuity Systems.
NXT-Dx has 1 investor. Key investors include Diagenode.